Non-Cochrane · prognostic · PM42041670

Malignant Transformation in Extraoral Lichen Planus: A Systematic Review and Meta-Analysis in the Context of the Risk in Oral Lichen Planus.

Colafemina Ana Carolina Evangelista, Pedroso Caique Mariano, Perez-de-Oliveira Maria Eduarda, et al. · Dentistry journal · 2026 · PubMed · doi:10.3390/dj14040217

Findings

4 findings

Population
Patients with extraoral lichen planus (cutaneous, genital or other non-oral mucosal sites)Presence of extraoral lichen planus (exposure)Not applicableMalignant transformation (proportion of patients developing cancer)
Follow-up as reported by each study · Subgroup analysis by site (vulvar plus cutaneous), overall model
Pooled proportion 0.02 [0.01, 0.04]
GRADE not reported
7 studies · 2575 participants
Patients with extraoral lichen planus (cutaneous, genital or other non-oral mucosal sites)Presence of extraoral lichen planus (exposure)Not applicableMalignant transformation (proportion of patients developing cancer)
Follow-up as reported by each study · Overall (all anatomical sites)
Pooled proportion 0.01 [0.00, 0.03]
GRADE not reported
8 studies · 15675 participants
Patients with extraoral lichen planus (cutaneous, genital or other non-oral mucosal sites)Presence of extraoral lichen planus (exposure)Not applicableMalignant transformation (proportion of patients developing cancer)
Follow-up as reported by each study · Vulvar lichen planus
Pooled proportion 0.02 [0.02, 0.03]
GRADE not reported
6 studies · 504 participants
Patients with cutaneous lichen planusPresence of extraoral lichen planusNone (single-group proportion)Malignant transformation (proportion of patients)
Cutaneous lichen planus cohort · Cutaneous
Proportion 0.00 [0.00, 0.01]
GRADE not reported
1 study · 2071 participants

Included primary studies 10

Open in Studies
StudyYearAlso included byOutcomes it informs hereTrial data
Boch 2021
Retrospective analysis of the clinical characteristics and patient-reported outcomes in vulval lichen planus: Results from a single-center…
PMID:34668211
2021this review onlyMalignant transformation (proportion of patients developing cancer)not extracted yet
Cooper 2006
Influence of treatment of erosive lichen planus of the vulva on its prognosis.
PMID:16549703
2006this review onlyMalignant transformation (proportion of patients developing cancer)not extracted yet
Fahy 2017
Lichen planus affecting the female genitalia: A retrospective review of patients at Mayo Clinic.
PMID:29031660
2017this review onlyMalignant transformation (proportion of patients developing cancer)not extracted yet
Halonen 2018
Cancer risk of Lichen planus: A cohort study of 13,100 women in Finland.
PMID:28857160
2018this review onlyMalignant transformation (proportion of patients developing cancer)not extracted yet
Hieta 2025
Risk of Vulvar HSIL and Penile Neoplasias in Anogenital Lichen Planus: A Case-Control Study.
PMID:39951645
2025this review onlynot statednot extracted yet
Kirtschig 2005
Mucosal vulval lichen planus: outcome, clinical and laboratory features.
PMID:15857455
2005this review onlyMalignant transformation (proportion of patients developing cancer)not extracted yet
Lyra 2021
Erosive Vulvar Lichen Planus and Risk of Vulvar Neoplasia.
PMID:33214502
2021this review onlyMalignant transformation (proportion of patients developing cancer)not extracted yet
Regauer 2014
Vulvar cancers in women with vulvar lichen planus: a clinicopathological study.
PMID:24999271
2014this review onlynot statednot extracted yet
Santegoets 2010
A retrospective study of 95 women with a clinical diagnosis of genital lichen planus.
PMID:20885160
2010this review onlyMalignant transformation (proportion of patients developing cancer)not extracted yet
Sigurgeirsson 1991
Lichen planus and malignancy. An epidemiologic study of 2071 patients and a review of the literature.
PMID:1952973
1991this review onlyMalignant transformation (proportion of patients developing cancer)not extracted yet

Review question

ElementPlanned (methods)Found (results)
PopulationPatients with extraoral lichen planus (cutaneous, genital, esophageal or other non-oral mucosal sites); clinical and/or histopathological diagnosisPatients with extraoral LP (n=15829; 93.1% female); sites mainly vulvar, also cutaneous, esophageal, ocular
InterventionPresence of extraoral LP (exposure)Extraoral LP (n=10 studies)
ComparisonNot applicableNot applicable
OutcomesPrevalence (proportion) of malignant transformationMalignant transformation: 100 cases reported; pooled proportion 1% (8 studies, n=15675)
Study designsCohort and case-control studies9 cohort studies and 1 case-control study; 8 cohort studies in meta-analysis
TimingNot specifiedFollow-up 19.3 to 72 months where reported